Valium description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Home SubjectClassCompaniesIngredientsNames A-Z
Search
Home – Valium

Valium

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

VALIUM DESCRIPTION



CLINICAL PHARMACOLOGY

Valium



Pharmacokinetics













Pharmacokinetics in Special Populations












INDICATIONS






VALIUM CONTRAINDICATIONS


WARNINGS





Pregnancy




Labor and Delivery


Nursing Mothers

PRECAUTIONS

General
Drug Interactions).

ADVERSE REACTIONS). Should this occur, use of the drug should be discontinued. These reactions are more likely to occur in children and the elderly.

DRUG ABUSE AND DEPENDENCE).



Information For Patients



Drug Interactions
















Carcinogenesis, Mutagenesis, Impairment of Fertility


Pregnancy
Category D(seeWARNINGS: Pregnancy).
Pediatric Use


Geriatric Use



Hepatic Insufficiency
CLINICAL PHARMACOLOGY: Pharmacokinetics in Special Populations: Hepatic Insufficiency).

VALIUM ADVERSE REACTIONS



Central Nervous System:


Gastrointestinal System:


Special Senses:


Cardiovascular System:


Psychiatric and Paradoxical Reactions:


Urogenital System:


Skin and Appendages:


Laboratories:


Other:




DRUG ABUSE AND DEPENDENCE





Rebound Anxiety:


OVERDOSAGE



Management of Overdosage


The prescriber should be aware of a risk of seizure in association with flumazenil treatment, particularly in long-term benzodiazepine users and in cyclic antidepressant overdose.Caution should be observed in the use of flumazenil in epileptic patients treated with benzodiazepines. The complete flumazenil package insert, includingCONTRAINDICATIONS, WARNINGS,andPRECAUTIONS,should be consulted prior to use.
 DRUG ABUSE AND DEPENDENCE).

DOSAGE & ADMINISTRATION


ADULTS: USUAL DAILY DOSE:

HOW SUPPLIED









STORAGE AND HANDLING


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Valium



Valium

diazepam TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-765(NDC:0140-0005)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DIAZEPAM DIAZEPAM 5 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
STARCH, CORN
CALCIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
yellow 9 mm 5;VALIUM;ROCHE;ROCHE ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-765-01 1 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA013263 2012-11-28


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.
Designed by Tank
Developed by KB.MD